[1]
do Nascimento TS, Pereira RO, de Mello HL, Costa J. Methemoglobinemia: from diagnosis to treatment. Revista brasileira de anestesiologia. 2008 Nov-Dec:58(6):651-64
[PubMed PMID: 19082413]
[2]
Ginimuge PR, Jyothi SD. Methylene blue: revisited. Journal of anaesthesiology, clinical pharmacology. 2010 Oct:26(4):517-20
[PubMed PMID: 21547182]
[3]
Li J, Chen X, Qi M, Li Y. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis. PloS one. 2018:13(9):e0204364. doi: 10.1371/journal.pone.0204364. Epub 2018 Sep 20
[PubMed PMID: 30235340]
Level 2 (mid-level) evidence
[4]
Salman AE, Salman MA, Saricaoglu F, Akinci SB, Aypar Ü. Pain on injection of propofol: a comparison of methylene blue and lidocaine. Journal of clinical anesthesia. 2011 Jun:23(4):270-4. doi: 10.1016/j.jclinane.2010.09.008. Epub
[PubMed PMID: 21663809]
[5]
Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prové A, Vermorken JB. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. British journal of cancer. 2000 Jan:82(2):291-4
[PubMed PMID: 10646879]
Level 3 (low-level) evidence
[6]
Ajithkumar T, Parkinson C, Shamshad F, Murray P. Ifosfamide encephalopathy. Clinical oncology (Royal College of Radiologists (Great Britain)). 2007 Mar:19(2):108-14
[PubMed PMID: 17355105]
[7]
Dudley NE. Methylene blue for rapid identification of the parathyroids. British medical journal. 1971 Sep 18:3(5776):680-1
[PubMed PMID: 5569552]
[8]
Olivier M, Van Den Ham K, Shio MT, Kassa FA, Fougeray S. Malarial pigment hemozoin and the innate inflammatory response. Frontiers in immunology. 2014:5():25. doi: 10.3389/fimmu.2014.00025. Epub 2014 Feb 5
[PubMed PMID: 24550911]
[9]
Küpfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet (London, England). 1994 Mar 26:343(8900):763-4
[PubMed PMID: 7510815]
[10]
Shanmugam G. Vasoplegic syndrome--the role of methylene blue. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2005 Nov:28(5):705-10
[PubMed PMID: 16143539]
[11]
Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. The Annals of thoracic surgery. 2004 Feb:77(2):496-9
[PubMed PMID: 14759425]
[12]
Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B, Müller O. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malaria journal. 2006 Oct 8:5():84
[PubMed PMID: 17026773]
[13]
Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. Journal of psychopharmacology (Oxford, England). 2011 Mar:25(3):429-36. doi: 10.1177/0269881109359098. Epub 2010 Feb 8
[PubMed PMID: 20142303]
Level 3 (low-level) evidence
[14]
Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia. 2003 Oct:58(10):1041-2
[PubMed PMID: 12969068]
[16]
Crooks J. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Archives of disease in childhood. 1982 Nov:57(11):872-3
[PubMed PMID: 6890790]
[18]
Kidd SA, Lancaster PA, Anderson JC, Boogert A, Fisher CC, Robertson R, Wass DM. Fetal death after exposure to methylene blue dye during mid-trimester amniocentesis in twin pregnancy. Prenatal diagnosis. 1996 Jan:16(1):39-47
[PubMed PMID: 8821851]
[19]
Gillman PK. Methylene blue implicated in potentially fatal serotonin toxicity. Anaesthesia. 2006 Oct:61(10):1013-4
[PubMed PMID: 16978328]